Spots Global Cancer Trial Database for Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
Official Title: Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Study ID: NCT02861287
Conditions
Interventions
Study Description
Brief Summary: This study aims to realize an economic evaluation of the introduction of Plerixafor in addition to G-CSF and alternative options, in patients with multiple myeloma (MM) who failed or insufficiently mobilize peripheral blood stem and progenitor cells in response to G-CSF alone.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institut Paoli-Calmettes, Marseille, Bouches-du Rhône, France
Contact Details
Name: Christian Chabannon, MD PhD
Affiliation: Institut Paoli-Calmettes
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
